Clinical Scorecard: Novel Functions of Transfer RNA-Derived Fragments in the Central Nervous System
At a Glance
Category
Detail
Condition
Neurological disorders including amyotrophic lateral sclerosis, epilepsy, Alzheimer's disease, Parkinson's disease, and ischaemic stroke
Key Mechanisms
tsRNAs modulate RNA levels and translation via miRNA-like targeting, interact with RNA binding proteins, interfere with translation machinery, and are influenced by chemical modifications inherited from tRNAs
Target Population
Neurons and other CNS cell types, with cell type-specific tsRNA expression profiles
Care Setting
Neurological research and potential future clinical diagnostics and therapeutics in CNS diseases
Key Highlights
tsRNAs are functional small non-coding RNAs derived from tRNAs, abundant especially in neurons within the CNS.
Disease-specific tsRNA profiles have been identified in multiple CNS disorders, with potential as biomarkers detectable in blood and CSF.
Mechanisms of tsRNA action include miRNA-like mRNA targeting, protein interactions, and modulation by tRNA-derived chemical modifications.
Guideline-Based Recommendations
Diagnosis
Consider profiling tsRNA signatures in blood or CSF as emerging biomarkers for CNS disorders such as epilepsy, Parkinson's disease, and stroke.
Management
Research into tsRNA functions may inform development of novel diagnostics and therapeutics tailored to age, sex, and disease-specific CNS conditions.
Monitoring & Follow-up
Monitor tsRNA levels and profiles longitudinally to assess disease progression and response to potential tsRNA-targeted interventions.
Risks
Excessive tsRNA production may deplete parent tRNA pools, potentially impairing protein translation and cellular growth under stress.
Patient & Prescribing Data
Patients with CNS disorders exhibiting disease-specific tsRNA alterations
No current direct treatments targeting tsRNAs; ongoing research may enable future therapeutic strategies based on modulating tsRNA levels or functions.
Clinical Best Practices
Utilize advanced sequencing techniques that remove tRNA modifications and chemically blocked ends to accurately profile tsRNAs.
Interpret tsRNA profiles in the context of patient age, sex, and specific neurological disease for precision medicine approaches.
Integrate tsRNA research findings with existing molecular and clinical data to enhance understanding of CNS disease mechanisms.
